| # | Title | Journal | Year | Citations |
|---|
| 1 | Long-term anti-TNF therapy and the risk of serious infections in a cohort of patients with rheumatoid arthritis: Comparison of adalimumab, etanercept and infliximab in the GISEA registry | Autoimmunity Reviews | 2012 | 146 |
| 2 | Efficacy and safety of rituximab treatment in early primary Sjögren's syndrome: a prospective, multi-center, follow-up study | Arthritis Research and Therapy | 2013 | 143 |
| 3 | GITR+ regulatory T cells in the treatment of autoimmune diseases | Autoimmunity Reviews | 2015 | 65 |
| 4 | Storm, typhoon, cyclone or hurricane in patients with COVID-19? Beware of the same storm that has a different origin | RMD Open | 2020 | 65 |
| 5 | A retrospective, multicenter study evaluating the prognostic value of minor salivary gland histology in a large cohort of patients with primary Sjögren’s syndrome | Lupus | 2015 | 63 |
| 6 | Is minor salivary gland biopsy more than a diagnostic tool in primary Sjo¨gren׳s syndrome? Association between clinical, histopathological, and molecular features: A retrospective study | Seminars in Arthritis and Rheumatism | 2014 | 61 |
| 7 | Efficacy and safety of off-label use of rituximab in refractory lupus: data from the Italian Multicentre Registry | Clinical and Experimental Rheumatology | 2015 | 55 |
| 8 | Influence of COVID-19 pandemic on decisions for the management of people with inflammatory rheumatic and musculoskeletal diseases: a survey among EULAR countries | Annals of the Rheumatic Diseases | 2021 | 54 |
| 9 | In vivo activated T cells in rheumatoid synovitis. Analysis of Th1- and Th2-type cytokine production at clonal level in different stages of disease | Clinical and Experimental Immunology | 2002 | 51 |
| 10 | Hypertension as a cardiovascular risk factor in autoimmune rheumatic diseases | Nature Reviews Cardiology | 2018 | 50 |
| 11 | Blue honeysuckle fruit (Lonicera caerulea L.) from eastern Russia: phenolic composition, nutritional value and biological activities of its polar extracts | Food and Function | 2016 | 40 |
| 12 | Thickened carotid artery intima-media in rheumatoid arthritis is associated with elevated anticardiolipin antibodies | Lupus | 2007 | 38 |
| 13 | One year in review 2017: primary Sjögren's syndrome | Clinical and Experimental Rheumatology | 2017 | 38 |
| 14 | One year in review 2021: Sjögren's syndrome | Clinical and Experimental Rheumatology | 2021 | 35 |
| 15 | Cardiovascular disease in systemic sclerosis | Annals of Translational Medicine | 2015 | 34 |
| 16 | One year in review 2016: spondyloarthritis | Clinical and Experimental Rheumatology | 2017 | 27 |
| 17 | One year in review 2016: Sjögren's syndrome | Clinical and Experimental Rheumatology | 2016 | 26 |
| 18 | Polar extracts from the berry-like fruits of Hypericum androsaemum L. as a promising ingredient in skin care formulations | Journal of Ethnopharmacology | 2017 | 23 |
| 19 | Rituximab in primary Sjögren's syndrome: a ten-year journey | Lupus | 2014 | 21 |
| 20 | One year in review 2016: systemic lupus erythematosus | Clinical and Experimental Rheumatology | 2016 | 15 |
| 21 | Patient–physician collaboration in rheumatology: a necessity | RMD Open | 2017 | 14 |
| 22 | Pathophysiology of acute respiratory syndrome coronavirus 2 infection: a systematic literature review to inform EULAR points to consider | RMD Open | 2021 | 14 |
| 23 | Effect of treatment with iloprost with or without bosentan on nailfold videocapillaroscopic alterations in patients with systemic sclerosis | Modern Rheumatology | 2017 | 13 |
| 24 | EULAR Points to Consider (PtC) for designing, analysing and reporting of studies with work participation as an outcome domain in patients with inflammatory arthritis | Annals of the Rheumatic Diseases | 2021 | 13 |
| 25 | Assessment of competences in rheumatology training: results of a systematic literature review to inform EULAR points to consider | RMD Open | 2020 | 12 |
| 26 | 2019 EULAR points to consider for the assessment of competences in rheumatology specialty training | Annals of the Rheumatic Diseases | 2021 | 12 |
| 27 | Young people’s perspectives on patient-reported outcome measures in inflammatory arthritis: results of a multicentre European qualitative study from a EULAR task force | RMD Open | 2021 | 10 |
| 28 | The prevalence and relevance of traditional cardiovascular risk factors in primary Sjögren's syndrome | Clinical and Experimental Rheumatology | 2018 | 10 |
| 29 | One year in review 2018: Sjögren's syndrome | Clinical and Experimental Rheumatology | 2018 | 10 |
| 30 | Strategies for the assessment of competences during rheumatology training across Europe: results of a qualitative study | RMD Open | 2020 | 9 |
| 31 | Methodological aspects of design, analysis and reporting of studies with work participation as an outcome domain in patients with inflammatory arthritis: results of two systematic literature reviews informing EULAR points to consider | RMD Open | 2021 | 9 |
| 32 | Italian recommendations for influenza and pneumococcal vaccination in adult patients with autoimmune rheumatic diseases | Clinical and Experimental Rheumatology | 2020 | 7 |
| 33 | Anti -citrullinated peptide antibodies profiling in established rheumatoid arthritis | Joint Bone Spine | 2018 | 6 |
| 34 | Multidisciplinary collaboration among young specialists: results of an international survey by the emerging EULAR network and other young organisations | RMD Open | 2020 | 6 |
| 35 | Validation study of predictive value of capillaroscopic skin ulcer risk index (CSURI) in scleroderma patients treated with bosentan | Clinical and Experimental Rheumatology | 2015 | 5 |
| 36 | The past, present and future of e-health in Rheumatology | Joint Bone Spine | 2021 | 4 |
| 37 | Persistence of focal lymphocytic sialadenitis in patients with primary Sjögren's syndrome treated with rituximab: a possible role for glandular BAFF | Clinical and Experimental Rheumatology | 2016 | 4 |
| 38 | Use of Rituximab in the Management of Sjögren’s Syndrome | Current Treatment Options in Rheumatology | 2015 | 3 |
| 39 | The challenge to interpret conflicting results and the need of a univocal definition for germinal centres in primary Sjögren’s syndrome | Annals of the Rheumatic Diseases | 2018 | 3 |
| 40 | Baseline characteristics of systemic lupus erythematosus patients included in the Lupus Italian Registry of the Italian Society for Rheumatology | Lupus | 2021 | 3 |
| 41 | Long-term Outcome of Children Born to Women with Autoimmune Rheumatic Diseases: A Multicentre, Nationwide Study on 299 Randomly Selected Individuals | Clinical Reviews in Allergy and Immunology | 2022 | 2 |
| 42 | EULAR portfolio for Rheumatology training: a EULAR School of Rheumatology initiative | RMD Open | 2021 | 2 |
| 43 | Italian recommendations for influenza and pneumococcal vaccination in adult patients with autoimmune rheumatic diseases | Clinical and Experimental Rheumatology | 2020 | 2 |
| 44 | AB0465 Etanercept therapy in rheumatoid arthritis patients with moderate or severe disease activity | Annals of the Rheumatic Diseases | 2013 | 1 |
| 45 | FRI0024 Interferon Gamma-Inducible Protein 16 (IFI16) in Rheumatoid Arthritis: A Novel Biomarker for Pulmonary Involvement? | Annals of the Rheumatic Diseases | 2015 | 1 |
| 46 | THU0341 Correlation between Essdai and Clinessdai in A Real-Life Cohort of Sjögren's Syndrome Patients: Table 1 | Annals of the Rheumatic Diseases | 2016 | 1 |
| 47 | SP0072 The Role of Health Professionals in Improving Shared Decision Making with Young People with RMDS | Annals of the Rheumatic Diseases | 2016 | 1 |
| 48 | Autoantibodies and interstitial lung disease in rheumatoid arthritis: towards a ‘mix-and-match’ approach? | Annals of the Rheumatic Diseases | 2022 | 1 |
| 49 | Comment on: Equal rights in autoimmunity: is Sjögren's syndrome ever ‘secondary’? | Rheumatology | 2021 | 1 |
| 50 | One year in review 2015: idiopathic inflammatory myopathies | Clinical and Experimental Rheumatology | 2015 | 1 |
